Home
Orbimed Advisors, Director: Prelude Therapeutics PRLD Buy · Filed 04/23
Trade details
- Type
- Insider buy
- Amount
- $7,499,999.16
- Shares · price
- 1,689,189 sh · $4.44 a share
- Held after
- 11,808,945 sh
- Person
- Orbimed AdvisorsDirector
- Trade date
- 26/04/21
- Filed
- 26/04/23
- Days to filing
- 2 days
First buy in 2 years
- Since the last buy
- 2.9 years
- Last buy
- 23/05/22
- Insiders buying this week
- 5 insiders
- Holding change
- +16.7%
Prelude Therapeutics trades, last 26 weeks
What else happened in Prelude Therapeutics around then
Filed or reported within 30 days of the trade day · 03/22~05/21Orbimed Advisors's recent trades
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
- Orbimed Advisors
BuyElectra Therapeutics
BuyElectra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
- Orbimed Advisors
BuyElectra Therapeutics
BuyElectra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21
